Tag: Ocugen

Biotechnology firm Ocugen has staged a remarkable recovery, with its share price more than doubling from its annual low of ...

Shares of biotechnology firm Ocugen have captured renewed investor interest after a prolonged period of stagnation. A significant analyst upgrade ...

Recent market analysis reveals a transformative growth trajectory for the retinal biologics sector, a development that could hold significant implications ...

Biotechnology firm Ocugen has generated significant market attention following the release of new clinical trial data for its experimental eye ...